Healthtech Investors & VC Firms

3408 firms in this list, with a median first check of $500K. 737 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
MA Magnetic Ventures CAJSUEIP9 people · Leads rounds	88🔒	Boston	US	Seed–Series A	$1M – $6M	+ Add to CRM
RA Rainmatter Follows rounds	88🔒	Bengaluru	IN	Seed–Series A	$60K – $12M	+ Add to CRM
82 82VS APDZEAHB17 people	88🔒	Boston	US	Pre-Seed–Seed	—	+ Add to CRM
CO Comet Labs LWMWABCC8 people	88🔒	San Francisco	US	Pre-Seed–Late Stage	—	+ Add to CRM
SC SCP Vitalife Partners ALJDWBWJ11 people	88🔒	Tel Aviv	IL	Seed–Late Stage	$3M – $7M	+ Add to CRM
VI Viola Credit AGEFIVAB14 people · Follows rounds	88🔒	London	GB	Pre-Seed–Late Stage	$2M – $50M	+ Add to CRM
KI Kinnevik AATS2 people	88🔒	Stockholm	SE	Seed–Late Stage	—	+ Add to CRM
TH The Yield Lab KWND2 people · Leads rounds	88🔒	Singapore	SG	Pre-Seed–Series A	$48K – $12M	+ Add to CRM
BA Backbone Ventures MSPBJRMK13 people · Leads rounds	88🔒	Zurich	CH	Pre-Seed–Seed	$330K – $440K	+ Add to CRM
FI Fika Ventures EHAAJCMH10 people	88🔒	Culver City	US	Seed–Series A	$250K – $2M	+ Add to CRM
RE Rebright Partners TEBBHIMK10 people	88🔒	Tokyo	JP	Pre-Seed–Series A	—	+ Add to CRM
RO Roche Venture Fund AHY(FGCC10 people	88🔒	Basel	CH	Seed–Growth	$648K – $3.2M	+ Add to CRM
HO Hongtai Capital Holdings	88🔒	Beijing	CN	Seed–Late Stage	—	+ Add to CRM
MC MC Healthcare Ventures SOJMAHHB6 people	88🔒	Cambridge	US	Seed–Series A	—	+ Add to CRM
SE Sentiero Ventures JEJGKKAC9 people · Leads rounds	88🔒	Dallas	US	Pre-Seed–Series A	$10K – $1M	+ Add to CRM
TI Time BioVentures DWTWTWBC15 people	88🔒	Southern California	US	Seed–Series A	—	+ Add to CRM
AN Analog Ventures JNLLJQPM11 people · Leads rounds	88🔒	San Francisco	US	Pre-Seed–Late Stage	$500K – $1.5M	+ Add to CRM
FO Foreground Capital EBSOAPES8 people · Leads rounds	88🔒	Boston	US	Pre-Seed–Series B	—	+ Add to CRM
GI Gilead Sciences DBJMSJDO17 people	88🔒	Foster City	US	Series B–Late Stage	—	+ Add to CRM
GI Gimv AJLTMMPV11 people · Leads rounds	88🔒	Antwerp	BE	Growth–Late Stage	$21M – $430M	+ Add to CRM
HI Highline Beta MDBYDBJM17 people	88🔒	Toronto	CA	Pre-Seed–Growth	—	+ Add to CRM
KE Kelvin Capital AHJMHLLH8 people	88🔒	Glasgow	GB	Seed–Late Stage	—	+ Add to CRM
ME Meron Capital DRGSGFLA5 people · Leads rounds	88🔒	Tel Aviv	IL	Pre-Seed–Series A	—	+ Add to CRM
PI Pivotal Life Sciences AKGBAVBL14 people · Follows rounds	88🔒	San Francisco	US	Seed–Late Stage	—	+ Add to CRM

Magnetic Ventures

BostonSeed–Series A$1M – $6M

CAJSUEIP9 people

Rainmatter

BengaluruSeed–Series A$60K – $12M

82VS

BostonPre-Seed–Seed

APDZEAHB17 people

Comet Labs

San FranciscoPre-Seed–Late Stage

LWMWABCC8 people

SCP Vitalife Partners

Tel AvivSeed–Late Stage$3M – $7M

ALJDWBWJ11 people

Viola Credit

LondonPre-Seed–Late Stage$2M – $50M

AGEFIVAB14 people

Kinnevik

StockholmSeed–Late Stage

AATS2 people

The Yield Lab

SingaporePre-Seed–Series A$48K – $12M

KWND2 people

Backbone Ventures

ZurichPre-Seed–Seed$330K – $440K

MSPBJRMK13 people

Fika Ventures

Culver CitySeed–Series A$250K – $2M

EHAAJCMH10 people

Rebright Partners

TokyoPre-Seed–Series A

TEBBHIMK10 people

Roche Venture Fund

BaselSeed–Growth$648K – $3.2M

AHY(FGCC10 people

Hongtai Capital Holdings

BeijingSeed–Late Stage

MC Healthcare Ventures

CambridgeSeed–Series A

SOJMAHHB6 people

Sentiero Ventures

DallasPre-Seed–Series A$10K – $1M

JEJGKKAC9 people

Time BioVentures

Southern CaliforniaSeed–Series A

DWTWTWBC15 people

Analog Ventures

San FranciscoPre-Seed–Late Stage$500K – $1.5M

JNLLJQPM11 people

Foreground Capital

BostonPre-Seed–Series B

EBSOAPES8 people

Gilead Sciences

Foster CitySeries B–Late Stage

DBJMSJDO17 people

Gimv

AntwerpGrowth–Late Stage$21M – $430M

AJLTMMPV11 people

Highline Beta

TorontoPre-Seed–Growth

MDBYDBJM17 people

Kelvin Capital

GlasgowSeed–Late Stage

AHJMHLLH8 people

Meron Capital

Tel AvivPre-Seed–Series A

DRGSGFLA5 people

Pivotal Life Sciences

San FranciscoSeed–Late Stage

AKGBAVBL14 people

Data sourced from public filings and firms' own websites — see our methodology.